ARENA PHARMACEUTICALS INC's ticker is ARNAXXXX and the CUSIP is 040047102. A total of 1 filers reported holding ARENA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $106,000 | -47.8% | 23,000 | -50.5% | 0.02% | -46.7% |
| Q1 2015 | $203,000 | +26.1% | 46,500 | 0.0% | 0.03% | +20.0% |
| Q4 2014 | $161,000 | -13.4% | 46,500 | +4.5% | 0.02% | -13.8% |
| Q3 2014 | $186,000 | -29.3% | 44,500 | -1.1% | 0.03% | -31.0% |
| Q2 2014 | $263,000 | -7.1% | 45,000 | 0.0% | 0.04% | -12.5% |
| Q1 2014 | $283,000 | +7.6% | 45,000 | 0.0% | 0.05% | +4.3% |
| Q4 2013 | $263,000 | +11.0% | 45,000 | 0.0% | 0.05% | +2.2% |
| Q3 2013 | $237,000 | -31.5% | 45,000 | 0.0% | 0.04% | -35.7% |
| Q2 2013 | $346,000 | – | 45,000 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MANGROVE PARTNERS IM, LLC | 867,700 | $5,085,000 | 1.68% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,369,066 | $25,603,000 | 1.03% |
| Lyons Wealth Management, LLC. | 56,775 | $334,000 | 0.30% |
| Callan Capital, LLC | 66,118 | $387,000 | 0.10% |
| QS BATTERYMARCH FINANCIAL MANAGEMENT, INC | 383,050 | $2,245,000 | 0.06% |
| FCG ADVISORS, LLC | 10,600 | $62,000 | 0.05% |
| OppenheimerFunds, Inc. | 7,000,000 | $41,020,000 | 0.04% |
| NEXT Financial Group, Inc | 19,704 | $86,000 | 0.04% |
| WELLINGTON MANAGEMENT GROUP LLP | 27,893,387 | $163,455,000 | 0.04% |
| MURPHY CAPITAL MANAGEMENT INC | 45,000 | $263,000 | 0.04% |